Sign In
Buy ENZ
$0.314
+0 (+0%)
At Close: Aug 01, 2025
Enzo Biochem, Inc. To be Acquired by Battery Ventures in All-Cash Transaction
07:00am, Tuesday, 24'th Jun 2025
Transaction Follows Completion of Comprehensive Strategic Review by Special Committee of the Board to Maximize Shareholder Value
Enzo Biochem Reports Third Quarter Fiscal Year 2025 Results
06:40pm, Monday, 16'th Jun 2025
FARMINGDALE, N.Y., June 16, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (OTCQX: ENZB) (“Enzo” or the “Company”) today announced financial results for the fiscal third quarter ended April 30, 2
Enzo Biochem, Inc. Announces Review of Strategic Alternatives after Receiving Multiple Inquiries Regarding a Potential Transaction
08:30am, Tuesday, 22'nd Apr 2025
Forms Special Committee of the Board to Lead Evaluation of Viable Options for Maximizing Shareholder Value
The Zacks Analyst Blog AbbVie, The TJX, The Charles Schwab, Enzo Biochem and CVD Equipment
05:35am, Wednesday, 16'th Apr 2025
AbbVie, The TJX, The Charles Schwab, Enzo Biochem and CVD Equipment are included in this Analyst Blog.
FARMINGDALE, N.Y., March 28, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced its intention to voluntarily delist its common stock from The New
Enzo Biochem Reports Second Quarter Fiscal Year 2025 Results
04:20pm, Monday, 17'th Mar 2025
FARMINGDALE, N.Y., March 17, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fiscal second quarter ended January 31,
Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules
04:15pm, Tuesday, 14'th Jan 2025
FARMINGDALE, N.Y, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced that it was notified by the New York Stock Exchange (the “NYSE”
ENZ Stock Falls Post Q1 Earnings Amid Revenue and Demand Challenges
09:51am, Thursday, 19'th Dec 2024
Enzo Biochem reports a first-quarter fiscal 2025 quarterly loss and revenue drop across regions amid challenges in the life sciences tools market.
Enzo Biochem Reports First Quarter Fiscal Year 2025 Results and Provides a Company Update
04:17pm, Monday, 16'th Dec 2024
FARMINGDALE, N.Y., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fiscal first quarter ended October 31, 2
ENZ Stock Up Following FY24 Earnings Uptick, Gross Margin Expands
12:50pm, Wednesday, 30'th Oct 2024
Enzo Biochem's overall topline benefits from revenue growth in the majority of its geographic regions.
Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash Dividend
07:59pm, Tuesday, 29'th Oct 2024
FARMINGDALE, N.Y., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fiscal fourth quarter ended July 31, 202
Enzo Biochem to pay $4.5 mln for failing to safeguard patient data
10:48am, Tuesday, 13'th Aug 2024
Enzo Biochem will pay $4.5 million to settle claims it failed to adequately safeguard personal and private health information of its patients, New York Attorney General Letitia James said on Tuedsay.
Enzo Biochem: Is This Time Finally Different?
12:49am, Wednesday, 17'th Jul 2024
Enzo Biochem shareholders frustrated with lack of capital returns following Clinical Labs sale to Labcorp Holdings. Stock trading near historic lows, but potential for attractive returns with simplifi
Zacks Initiates Coverage of Enzo Biochem With Neutral Recommendation
09:46am, Thursday, 20'th Jun 2024
Discover why Zacks rates Enzo Biochem as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore ENZ's notable revenue growth and financial health amid market challenges.
Enzo Biochem (ENZ) Q3 Earnings Improve Y/Y, Gross Margin Up
02:20pm, Friday, 14'th Jun 2024
Enzo Biochem's (ENZ) overall topline benefits from revenue growth in the majority of its geographic regions.
